¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"ghost cell glaucoma"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
acinar cell
»ù²Ê¸®¼¼Æ÷, ¼¼¿±¼¼Æ÷
acinar cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
adult T-cell leukemia/lymphoma
¼ºÀÎT¼¼Æ÷¹éÇ÷º´/¸²ÇÁÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
anaplastic large cell lymphoma
¿ªÇü¼ºÅ«¼¼Æ÷¸²ÇÁÁ¾
basal cell
¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
basal cell adenoma
¹Ù´Ú¼¼Æ÷»ùÁ¾, ±âÀú¼¼Æ÷¼±Á¾
basal cell carcinoma
¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
basal cell epithelioma
¹Ù´Ú¼¼Æ÷»óÇÇÁ¾, ±âÀú¼¼Æ÷»óÇÇÁ¾
basal cell nevus
¹Ù´Ú¼¼Æ÷¸ð¹Ý, ±âÀú¼¼Æ÷¸ð¹Ý
basal cell nevus syndrome
¹Ù´Ú¼¼Æ÷¸ð¹ÝÁõÈıº, ±âÀú¼¼Æ÷¸ð¹ÝÁõÈıº
basket cell
¹Ù±¸´Ï¼¼Æ÷
basophilic cell
È£¿°±â¼¼Æ÷
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
round cell
¿øÇü¼¼Æ÷
satellite cell
À§¼º¼¼Æ÷
scavenger cell
û¼Ò¼¼Æ÷
Schwann's cell
½Å°æÁý¼¼Æ÷
signet ring cell carcinoma
¹ÝÁö¼¼Æ÷¾ÏÁ¾
signet-ring cell
¹ÝÁö¼¼Æ÷
small cell carcinoma
¼Ò¼¼Æ÷¾ÏÁ¾
spindle cell
¹æÃß¼¼Æ÷
squamous cell carcinoma
ÆíÆò¼¼Æ÷¾ÏÁ¾
squamous cell in situ carcinoma
ÆíÆò¼¼Æ÷»óÇdz»¾ÏÁ¾, ÆíÆò¼¼Æ÷¾ÏÁ¾
stellate cell
º°¼¼Æ÷
stem cell
Áٱ⼼Æ÷
supporting cell
¹öÆÀ¼¼Æ÷
sustentacular cell
(¢¡supporting cell) ¹öÆÀ¼¼Æ÷
target cell
Ç¥Àû¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
antigen-reactive cell
Ç׿ø¹ÝÀÀ¼¼Æ÷
antigen-recognizing cell
Ç׿øÀÎÁö¼¼Æ÷
argentaffin cell
ģũ·ÒÀº¼¼Æ÷
argyrophilic cell
ÀºÄ£È¼¼Æ÷
asexual cell
¹«¼º¼¼Æ÷
basal cell adenoma
±âÀú¼¼Æ÷»ùÁ¾, ¹Ù´Ú¼¼Æ÷¾ÏÁ¾
basosqumaous cell acanthoma
±âÀúÆíÆò¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
cell-associated antibody
¼¼Æ÷ºÎÂøÇ×ü
cell-bound antibody
(¢¡cell-fixed antibody) ¼¼Æ÷°áÇÕÇ×ü
cell-fixed antibody
¼¼Æ÷°áÇÕÇ×ü
clear cell acanthoma
Åõ¸í¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
clear cell adenocarcinoma
Åõ¸í¼¼Æ÷»ù¾ÏÁ¾
crescent cell anemia
Ãʽ´ÞÀûÇ÷±¸ºóÇ÷
helper cell activity
µµ¿ò¼¼Æ÷´É, Á¶·Â¼¼Æ÷´É
islet cell adenoma
¼¶¼¼Æ÷»ùÁ¾
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
B cell hybridoma
B¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
B cell lymphoma
B¼¼Æ÷¸²ÇÁÁ¾
B cell stimulating factor (BSF)
B¼¼Æ÷ ÀÚ±ØÀÎÀÚ
B cell study
B ¼¼Æ÷°Ë»ç
B cell/lymphocyte
B ¼¼Æ÷/¸²ÇÁ±¸
B-cell
ºñ ¼¼Æ÷
C-cell
C ¼¼Æ÷
CD4+ cell
CD4+ ¼¼Æ÷
Cell adhesion molecules
¼¼Æ÷À¯ÂøºÐÀÚ
Chinese hamster ovary tumor cell
Áß±¹ÇÔ½ºÅÍ ³¼Ò¼¼Æ÷, CHO¼¼Æ÷
Graham cell
±×¶óÇÔ¼¼Æ÷
Granulosa cell
°ú¸³¸·¼¼Æ÷(Î¨Ø£Ø¯á¬øà)
Granulosa cell tumor
°ú¸³¸·¼¼Æ÷Á¾¾ç(Î¨Ø£Ø¯á¬øàðþåË)
H-9 cell line
H-9 ¼¼Æ÷°è
HeLa cell
Çï¶ó¼¼Æ÷.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
pigmentary glaucoma
»ö¼Ò³ì³»Àå
post-irradiation glaucoma
¹æ»ç¼±³ì³»Àå
primary angle-closure glaucoma
¿ø¹ßÆó¼â°¢³ì³»Àå
primary glaucoma
¿ø¹ß³ì³»Àå(ê«Û¡ÖàÒ®î¡).
primary glaucoma ³ª g. primarium
¿ø¹ß³ì³»Àå(ê«Û¡ÖàÒ®î¡)
primary open-angle glaucoma
¿ø¹ß°³¹æ°¢³ì³»Àå
prodromal glaucoma
Àü±¸(±â)³ì³»Àå
pseudoexfoliation glaucoma
°¡¼ººñ´Ã³ì³»Àå, °¡¼º³«¼³³ì³»Àå
pupillary block glaucoma
µ¿°øÂ÷´Ü³ì³»Àå
radiation glaucoma
¹æ»ç¼±³ì³»Àå
rubeotic glaucoma
½Å»ýÇ÷°ü³ì³»Àå
secondary glaucoma
¼Ó¹ß³ì³»Àå(áÙÛ¡ÖàÒ®î¡), ÀÌÂ÷³ì³»Àå
secondary glaucoma
¼Ó¹ß¼º ³ì³»Àå(áÙÛ¡àõÖàÒ®î¡)
simple glaucoma
´Ü¼ø(¼º) ³ì³»Àå (¡ÖàÒ®î¡)
steroid glaucoma
½ºÅ×·ÎÀ̵å³ì³»Àå
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½